<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">Our initial understanding on incidence of arrhythmias in the SARS-CoV-2 outbreak was from retrospective studies from Wuhan, China. In a case series of 137 patients of coronavirus in tertiary hospitals in the Hubei province in China, nearly 7.3% reported palpitations as the initial symptom (
 <xref rid="bib13" ref-type="bibr">13</xref>). In another similarly sized study, 16.7% of patients were reported to have arrhythmias, with a higher incidence of 44.4% versus 6.9% in intensive care unit (ICU) patients compared with non-ICU patients (
 <xref rid="bib14" ref-type="bibr">14</xref>). A low prevalence of arrhythmias is noted among clinically stable COVID-19 patients in a single-day snapshot survey-based data (
 <xref rid="bib15" ref-type="bibr">15</xref>). A case series by Guo etÂ al. (
 <xref rid="bib6" ref-type="bibr">6</xref>) reported an occurrence of 5.9% of sustained episodes of ventricular tachycardia or ventricular fibrillation in 187 hospitalized COVID-19 patients.
</p>
